New Lab Approach Identifies Early-Stage Insulin Resistance, a Precursor to Prediabetes and Type 2 Diabetes, Finds Study in Journal of Endocrine Society

Innovation

A novel laboratory method can aid the identification of insulin resistance (IR), a precursor to prediabetes and type 2 diabetes, according to a study published in Journal of the Endocrine Society.

A Dangerous Pattern: High Rates of Drug Combining to be Revealed by Quest Diagnostics at 2018 AAFP Conference

Insights

The American Academy of Family Physicians (AAFP) conference is an annual event that explores family medicine from all angles. This year’s meeting – October 9-13 in New Orleans – will gather over 4,000 physicians from across the country to share best practices and learn from each other. Among the topics to be a major area of […]

Quest Diagnostics Collaborates with Leading Physicians in Hereditary Cancer Study

Insights

Quest Diagnostics, Inc. is the exclusive genetic-testing partner for the BRCA Founder Outreach Study (BFOR), which offers BRCA testing to 4,000 Ashkenazi-Jewish men and women in four major metropolitan U.S. cities: New York, Los Angeles, Philadelphia, and Boston.  One of the BFOR Study’s main goals is to explore new ways our healthcare system can use genetic testing […]

Cytogenetic Analysis in Chronic Lymphocytic Leukemia (CLL): The Rediscovered Value of Metaphase Chromosome Analysis

Insights

B-cell chronic lymphocytic leukemia (CLL) is the most common adult leukemia in the western world, and has a highly variable clinical course, ranging from indolent to highly aggressive.

If I had only known:  Congenital CMV infection prevention, diagnosis, and treatment

Insights

Newborn cytomegalovirus (CMV) testing is not routinely performed, and most pregnant women are not aware of congenital CMV infection prevention or potential risk in pregnancy.

Resources for Lyme Disease for Healthcare Professionals and Patients

Better Health

Accurate, unbiased information on Lyme disease and related tick-borne illnesses is critical for decision-making and patient care.

American Cancer Society Lowers Colorectal Cancer Screening to Age 45, Adds Additional Testing Options in Updated Guidelines

Better Health

This change in ACS guidelines would allow approximately 21 million people more to have access to colorectal cancer screening. 

Case Report of a Rare Fetal Chimera

Insights

Congenital chimeras are rare and often come to attention due to ambiguous genitalia or a discrepancy in the sex chromosome